Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 36. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_3237	Herpes simplex virus	wild type	DNA	Herpesviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3238	Herpes simplex virus	wild type	DNA	Herpesviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3239	Herpes simplex virus	wild type	DNA	Herpesviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3240	Herpes simplex virus	wild type	DNA	Herpesviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3241	Herpes simplex virus	wild type	DNA	Herpesviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	90% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3242	Herpes simplex virus	wild type	DNA	Herpesviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3243	Reovirus	wild type	RNA	Reoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3244	Reovirus	wild type	RNA	Reoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3245	Reovirus	wild type	RNA	Reoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3246	Reovirus	wild type	RNA	Reoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3247	Reovirus	wild type	RNA	Reoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3248	Reovirus	wild type	RNA	Reoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3249	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3250	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3251	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	75% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3252	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	72% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3253	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3254	Vaccinia virus	wild type	DNA	Poxviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	55% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3255	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	77% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3256	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3257	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	52% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3258	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	48% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3259	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	30% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3260	Vesicular stomatitis virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	25% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3261	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3262	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3263	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	27% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3264	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	22% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3265	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	20% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3266	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_4087	Vaccinia virus	VVstrain LIVP 6.1.1	DNA	Poxviridae	Mutant for J2R gene	Yes	No	No	University of colorado, USA	Human canine soft tissue sarcoma	STSA-1	NA	NA	MTT assay	0.1 MOI	100% cell survival after 24 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4091	Vaccinia virus	VVstrain LIVP 6.1.1	DNA	Poxviridae	Mutant for J2R gene	Yes	No	No	University of colorado, USA	Human canine soft tissue sarcoma	STSA-1	NA	NA	MTT assay	0.1 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4095	Vaccinia virus	VVstrain LIVP 6.1.1	DNA	Poxviridae	Mutant for J2R gene	Yes	No	No	University of colorado, USA	Human canine soft tissue sarcoma	STSA-1	NA	NA	MTT assay	0.1 MOI	40% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4099	Vaccinia virus	VVstrain GLV-5b451	DNA	Poxviridae	Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Yes	No	No	University of colorado, USA	Human canine soft tissue sarcoma	STSA-1	NA	NA	MTT assay	0.1 MOI	95% cell survival after 24 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4103	Vaccinia virus	VVstrain GLV-5b451	DNA	Poxviridae	Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Yes	No	No	University of colorado, USA	Human canine soft tissue sarcoma	STSA-1	NA	NA	MTT assay	0.1 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	NA	NA	26205404
OV_4107	Vaccinia virus	VVstrain GLV-5b451	DNA	Poxviridae	Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus	Yes	No	No	University of colorado, USA	Human canine soft tissue sarcoma	STSA-1	NA	NA	MTT assay	0.1 MOI	50% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	26205404